Friday, January 17, 2020 5:15:01 PM
Anthony M. Manning, Momenta Pharmaceuticals's Chief Scientific Officer, recently cashed-in 29,114 options. The options were exercised at prices ranging between $17.96 and $18.85, while the disposals took place at $28.44 per share, on January 15, 2020. Manning continues to hold 5,443 shares of the company. Manning operates out of Cambridge, MA.
Jo Ann Beltramello, Momenta Pharmaceuticals's Chief HR and Inf. Officer, recently cashed-in 43,194 options. The options were exercised at prices ranging between $17.96 and $18.85, while the disposals took place between $28.44 and $30.71 per share, on January 15, 2020. Beltramello continues to hold 42,452 shares of the company.
Jo Ann's getting new shoes. Amazing that she can do any work with all the trading she does. Jo Ann had a $4 million dollar week. Not Bad.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM